Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

7.0K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
7.0K
Case Studies01:22

Case Studies

11.7K
There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
11.7K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Special Staining Techniques01:13

Special Staining Techniques

63
Specialized staining techniques play a vital role in microbiology by enabling the visualization of specific bacterial structures that remain undetectable with standard microscopy methods. These techniques not only enhance the structural visualization of bacterial cells but also provide critical insights into their pathogenicity and classification. Additionally, they support diagnostic and research endeavors in microbiology by identifying key bacterial features.Capsule Staining for Virulence...
63
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

2.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
2.1K
Chemical Shift: Internal References and Solvent Effects01:17

Chemical Shift: Internal References and Solvent Effects

684
In an NMR sample, precise measurement of the absolute absorption frequencies of nuclei is difficult. A standard internal reference compound is added, and the frequency difference between the reference signal and sample signals is measured.
The internal reference compound generally used in NMR spectroscopy is tetramethylsilane (TMS). TMS is preferred because it is chemically inert, soluble in NMR solvents, and easily removable. Also, the highly shielded methyl protons in TMS yield an intense...
684

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: Collagen VI is a fibrosis-associated signal disrupting muscle regeneration across distinct human myopathies.

EMBO reports·2026
Same author

Phylogeny of SK channels and functional characterization of the conserved Phe in the S3-S4 loop.

Biophysical journal·2026
Same author

Collagen VI is a fibrosis-associated signal disrupting muscle regeneration across distinct human myopathies.

EMBO reports·2026
Same author

Stearoyl-CoA Desaturase-1 Drives Tumor Growth by Interacting With Histone Deacetylase-2 and Deacetylating Nucleophosmin-1.

MedComm·2026
Same author

Exhausted CD4<sup>+</sup>T cells are associated with CCL4-driven immunosuppressive macrophage accumulation in enzootic bovine leukosis.

Frontiers in immunology·2026
Same author

Pathogenic IgG from long COVID patients with neurological sequelae triggers sensitive but not cognitive impairments upon transfer into mice.

Acta neuropathologica·2026

Related Experiment Video

Updated: Jul 27, 2025

High Resolution Quantitative Synaptic Proteome Profiling of Mouse Brain Regions After Auditory Discrimination Learning
10:36

High Resolution Quantitative Synaptic Proteome Profiling of Mouse Brain Regions After Auditory Discrimination Learning

Published on: December 15, 2016

10.6K

Specific

Florent Porquet1,2,3, Lin Weidong1, Kévin Jehasse2

  • 1Laboratory of Molecular and Cellular Epigenetics, GIGA-Cancer, ULiège, 4000 Liège, Belgium.

Molecular Therapy. Nucleic Acids
|June 5, 2023
PubMed
Summary
This summary is machine-generated.

Researchers explored CRISPR interference to silence the DMPK gene promoter, reducing toxic RNA in myotonic dystrophy type 1 (DM1) cells. This approach offers a promising therapeutic strategy by correcting cellular abnormalities.

Keywords:
CRISPRiMT: RNA/DNA Editinggene silencinggene therapymyotonic dystrophy type 1neuromuscular disease

More Related Videos

Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization
12:11

Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization

Published on: February 27, 2020

6.9K
The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes
09:47

The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes

Published on: May 25, 2018

6.9K

Related Experiment Videos

Last Updated: Jul 27, 2025

High Resolution Quantitative Synaptic Proteome Profiling of Mouse Brain Regions After Auditory Discrimination Learning
10:36

High Resolution Quantitative Synaptic Proteome Profiling of Mouse Brain Regions After Auditory Discrimination Learning

Published on: December 15, 2016

10.6K
Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization
12:11

Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization

Published on: February 27, 2020

6.9K
The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes
09:47

The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes

Published on: May 25, 2018

6.9K

Area of Science:

  • Genetics and Molecular Biology
  • Neuromuscular Disorders
  • RNA Biology

Background:

  • Myotonic dystrophy type 1 (DM1) is caused by expanded CTG repeats in the DMPK gene, leading to toxic RNA aggregates.
  • These aggregates sequester MBNL splicing factors, causing misregulation and DM1 symptoms.
  • Current treatments focus on eliminating toxic RNA, with no cure available.

Purpose of the Study:

  • To investigate DMPK promoter silencing using CRISPR interference (CRISPRi) as a novel therapeutic strategy for DM1.
  • To evaluate the efficacy of different sgRNAs in reducing DMPK transcripts and CUGexp RNA aggregates.

Main Methods:

  • DM1 patient muscle cells were treated with various sgRNAs targeting the DMPK promoter.
  • CRISPR interference was employed to achieve promoter silencing.
  • Transcriptome-wide expression analysis was performed to assess specificity and off-target effects.

Main Results:

  • Effective sgRNAs reduced DMPK transcripts and CUGexp RNA aggregates by up to 80%.
  • DMPK promoter silencing corrected transcriptome-wide splicing defects (spliceopathy).
  • A key physiological parameter in DM1 muscle cells was reversed, and the effect was specific to the DMPK gene.

Conclusions:

  • CRISPRi-mediated DMPK promoter silencing is a viable and promising therapeutic approach for DM1.
  • This strategy effectively reduces toxic RNA and corrects cellular dysfunction in DM1 models.
  • The specificity of the CRISPRi approach ensures targeted therapeutic action.